4-Hydroperoxyisophosphamide - Dekk-Tec
Alternative Names: HOO-IFOS; HOOILatest Information Update: 28 Jun 2022
At a glance
- Originator Dekk-Tec
- Class Amides; Antineoplastics
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Jun 2022 No recent reports of development identified for preclinical development in Cancer in USA
- 28 May 2018 Preclinical development in Cancer is ongoing in USA (unspecified route) (Dekk-Tec pipeline, May 2018)
- 28 May 2018 Dekk-Tec receives SBIR grant from National Cancer Institute for 4-hydroperoxyifosfamide development in Cancer before May 2018 (Dekk-Tec pipeline, May 2018)